Pancreatic Cancer Trial, Recruiting NCT06499792 Sponsor: University Hospital, Strasbourg, France Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT06499792
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older.
  • People who had planned surgery to remove part or all of the pancreas and duodenum (a section of the small intestine), with or without additional blood vessel or liver surgery performed through an open abdominal incision, at Strasbourg University Hospital between June 1, 2022 and May 31, 2024.
  • People who have not objected to their medical data being used for scientific research purposes.

Who may not be able to join:

  • People who have stated they do not want to take part in this study.
  • People who were admitted to an intensive care unit following their surgery.
  • People with a history of drug addiction, whether currently using or not.
  • People whose surgery was cut short due to a decision made by the surgical team during the operation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 3 88 12 70 75

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 January 2024
Est. completion
1 December 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Consumption of Morphine in the first 24 hours postoperatively.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov